IBDEI15A ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19123,0)
 ;;=Z98.62^^94^917^73
 ;;^UTILITY(U,$J,358.3,19123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19123,1,3,0)
 ;;=3^Peripheral Vascular Angioplasty Status
 ;;^UTILITY(U,$J,358.3,19123,1,4,0)
 ;;=4^Z98.62
 ;;^UTILITY(U,$J,358.3,19123,2)
 ;;=^5063743
 ;;^UTILITY(U,$J,358.3,19124,0)
 ;;=Z98.84^^94^917^12
 ;;^UTILITY(U,$J,358.3,19124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19124,1,3,0)
 ;;=3^Bariatric Surgery Status
 ;;^UTILITY(U,$J,358.3,19124,1,4,0)
 ;;=4^Z98.84
 ;;^UTILITY(U,$J,358.3,19124,2)
 ;;=^5063749
 ;;^UTILITY(U,$J,358.3,19125,0)
 ;;=Z99.2^^94^917^141
 ;;^UTILITY(U,$J,358.3,19125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19125,1,3,0)
 ;;=3^Renal Dialysis Dependence
 ;;^UTILITY(U,$J,358.3,19125,1,4,0)
 ;;=4^Z99.2
 ;;^UTILITY(U,$J,358.3,19125,2)
 ;;=^5063758
 ;;^UTILITY(U,$J,358.3,19126,0)
 ;;=Z99.81^^94^917^144
 ;;^UTILITY(U,$J,358.3,19126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19126,1,3,0)
 ;;=3^Supplemental Oxygen Dependence
 ;;^UTILITY(U,$J,358.3,19126,1,4,0)
 ;;=4^Z99.81
 ;;^UTILITY(U,$J,358.3,19126,2)
 ;;=^5063760
 ;;^UTILITY(U,$J,358.3,19127,0)
 ;;=Z90.79^^94^917^2
 ;;^UTILITY(U,$J,358.3,19127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19127,1,3,0)
 ;;=3^Acquired Absence of Genital Organs NEC
 ;;^UTILITY(U,$J,358.3,19127,1,4,0)
 ;;=4^Z90.79
 ;;^UTILITY(U,$J,358.3,19127,2)
 ;;=^5063596
 ;;^UTILITY(U,$J,358.3,19128,0)
 ;;=Z90.5^^94^917^3
 ;;^UTILITY(U,$J,358.3,19128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19128,1,3,0)
 ;;=3^Acquired Absence of Kidney
 ;;^UTILITY(U,$J,358.3,19128,1,4,0)
 ;;=4^Z90.5
 ;;^UTILITY(U,$J,358.3,19128,2)
 ;;=^5063590
 ;;^UTILITY(U,$J,358.3,19129,0)
 ;;=Z90.2^^94^917^6
 ;;^UTILITY(U,$J,358.3,19129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19129,1,3,0)
 ;;=3^Acquired Absence of Lung (part of)
 ;;^UTILITY(U,$J,358.3,19129,1,4,0)
 ;;=4^Z90.2
 ;;^UTILITY(U,$J,358.3,19129,2)
 ;;=^5063585
 ;;^UTILITY(U,$J,358.3,19130,0)
 ;;=Z98.1^^94^917^10
 ;;^UTILITY(U,$J,358.3,19130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19130,1,3,0)
 ;;=3^Arthrodesis Status
 ;;^UTILITY(U,$J,358.3,19130,1,4,0)
 ;;=4^Z98.1
 ;;^UTILITY(U,$J,358.3,19130,2)
 ;;=^5063734
 ;;^UTILITY(U,$J,358.3,19131,0)
 ;;=Z94.7^^94^917^16
 ;;^UTILITY(U,$J,358.3,19131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19131,1,3,0)
 ;;=3^Corneal Transplant Status
 ;;^UTILITY(U,$J,358.3,19131,1,4,0)
 ;;=4^Z94.7
 ;;^UTILITY(U,$J,358.3,19131,2)
 ;;=^5063661
 ;;^UTILITY(U,$J,358.3,19132,0)
 ;;=Z83.511^^94^917^30
 ;;^UTILITY(U,$J,358.3,19132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19132,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,19132,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,19132,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,19133,0)
 ;;=Z80.52^^94^917^33
 ;;^UTILITY(U,$J,358.3,19133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19133,1,3,0)
 ;;=3^Family Hx of Malig Neop of Baldder
 ;;^UTILITY(U,$J,358.3,19133,1,4,0)
 ;;=4^Z80.52
 ;;^UTILITY(U,$J,358.3,19133,2)
 ;;=^5063352
 ;;^UTILITY(U,$J,358.3,19134,0)
 ;;=Z80.51^^94^917^36
 ;;^UTILITY(U,$J,358.3,19134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19134,1,3,0)
 ;;=3^Family Hx of Malig Neop of Kidney
 ;;^UTILITY(U,$J,358.3,19134,1,4,0)
 ;;=4^Z80.51
 ;;^UTILITY(U,$J,358.3,19134,2)
 ;;=^321159
 ;;^UTILITY(U,$J,358.3,19135,0)
 ;;=Z83.41^^94^917^43
 ;;^UTILITY(U,$J,358.3,19135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19135,1,3,0)
 ;;=3^Family Hx of Mult Endocrine Neoplasia Syndrome
 ;;^UTILITY(U,$J,358.3,19135,1,4,0)
 ;;=4^Z83.41
 ;;^UTILITY(U,$J,358.3,19135,2)
 ;;=^5063380
 ;;^UTILITY(U,$J,358.3,19136,0)
 ;;=Z81.8^^94^917^50
